Skip to content

An analysis of perioperative clinical characteristics and prognosis of proliferative diabetic retinopathy in children and adolescents: A multicenter retrospective cohort study

An analysis of perioperative clinical characteristics and prognosis of proliferative diabetic retinopathy in children and adolescents: A multicenter retrospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200057374
Enrollment
Unknown
Registered
2022-03-10
Start date
2022-03-10
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic retinopathy

Interventions

children and adolescents PDR:none
adults PDR:none

Sponsors

shanghai general hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The age of diagnosis of diabetes is less than 20 years old (children) or more than 20 years old (adults), gender is not limited, and there is no limit to single eye disease; 2. Patients with proliferative diabetes retinopathy diagnosed and undergoing PPV surgery have any of the following signs: 1) Obvious neovascularization, 2) preretinal hematocele, 3) vitreous hemorrhage; 3. Volunteer to participate in this clinical trial and sign the informed consent form; 4. They are willing to follow up and can follow up at the specified time.

Exclusion criteria

Exclusion criteria: 1. Other serious eye diseases except diabetes retinopathy, such as uveitis, retinal angiopathy, congenital and traumatic vitreoretinopathy, endophthalmitis, etc; 2. The patient did not receive PPV surgery or had less than 2 follow-up times or did not follow up as required; 3. Patients with serious systemic diseases, including abnormal liver and kidney functions, abnormal blood routine and coagulation functions, congenital heart disease and hearing impairment.

Design outcomes

Primary

MeasureTime frame
best corrected visaul acuity;central foveal thickness;

Secondary

MeasureTime frame
Postoperative vitreous hemorrhage;Postoperative neovascular glaucoma;

Countries

China

Contacts

Public ContactChuandi Zhou

shanghai general hospital

chuandi.zhou@shgh.cn+86 21 63240090-2419

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026